subject: Parkinson's Disease - Drug Pipeline Analysis And Market Forecasts To 2015 [print this page] Parkinsons Disease - Drug Pipeline Analysis and Market Forecasts to 2015
Summary
The industry analysis specialists new report, Parkinsons Disease - Drug Pipeline Analysis and Market Forecasts to 2015 is an essential source of information and analysis on the global Parkinsons disease market. The report identifies the key trends shaping and driving the global Parkinsons disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global Parkinsons disease sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by team of industry experts.
Scope
The scope of the report includes:
* Annualized global Parkinsons disease market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
* Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
* Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action includes dopamine agonists, adenosine receptor antagonists, serotonin receptor targetters, glutamate receptor antagonists, NMDA receptor targetters, AMPA receptor antagonists, stem cell and gene therapy.
* Analysis of the current and future market competition in the global Parkinsons disease market. Key future market players covered are Merck Serono, Acadia Pharmaceuticals, Axxonis Pharma AG, Avicena Group Inc., and Solvay Pharmaceuticals.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with Parkinsons disease.
